Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Bioasis Technologies Inc patents


Recent patent applications related to Bioasis Technologies Inc. Bioasis Technologies Inc is listed as an Agent/Assignee. Note: Bioasis Technologies Inc may have other listings under different names/spellings. We're not affiliated with Bioasis Technologies Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Bioasis Technologies Inc-related inventors


Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes

The present invention provides for compositions and methods for treating, ameliorating or preventing a lysosomal storage disease by administering to a patient suffering front a lysosomal storage disease a p97 conjugated with art enzyme which is capable of transportation into the lysosomes of cells on either sides of the blood brain barrier.. . ... Bioasis Technologies Inc

Antibodies against p97 and conjugates thereof

Provided are conjugates between (a) an antibody or antigen-binding fragment thereof that binds to p97 (melanotransferrin; mtf) and (b) an agent of interest, and related compositions and methods, for example, to improve pharmacokinetics and/or delivery of the agent of interest across the blood-brain barrier (bbb) and into tissues of the central nervous system (cns).. . ... Bioasis Technologies Inc

P97-ids fusion proteins

Provided are fusion proteins between p97 (melanotransferrin) and iduronate-2-sulfatase (ids), and related compositions and methods of use thereof, for instance, to facilitate delivery of ids across the blood-brain barrier (bbb) and/or improve its tissue penetration in cns and/or peripheral tissues, and thereby treat and/or diagnose hunter syndrome (mucopolysaccharidosis type ii; mps ii) and related lysosomal storage disorders, including those having a central nervous system (cns) component.. . ... Bioasis Technologies Inc

P97-polynucleotide conjugates

Provided are conjugates between p97 (melanotransferrin) and polynucleotides such as small interfering rna (sirna) molecules, and related compositions and methods of use thereof, for instance, to facilitate delivery of polynucleotides such as sirna molecules across the blood-brain barrier (bbb) and/or improve their tissue penetration in cns and/or peripheral tissues, and thereby treat and/or diagnose various diseases, including those having a central nervous system (cns) component.. . ... Bioasis Technologies Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Bioasis Technologies Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Bioasis Technologies Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###